These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 2149051

  • 21. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
    Chuang YY, Hung IJ, Yang CP, Jaing TH, Lin TY, Huang YC.
    Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S, Raccah R, Santilli S, Micozzi A, Girmena C, Martino P, Avvisati G.
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients.
    Smith CL, Milliken S, Powles R, Da Costa F, Gore M, Benjamin S, Talbot D, Ellis L, Large J, Jameson B.
    Br J Haematol; 1990 Dec; 76 Suppl 2():6-9. PubMed ID: 2149055
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.
    Ramphal R, Bolger M, Oblon DJ, Sherertz RJ, Malone JD, Rand KH, Gilliom M, Shands JW, Kramer BS.
    Antimicrob Agents Chemother; 1992 May; 36(5):1062-7. PubMed ID: 1510394
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
    Peacock JE, Herrington DA, Wade JC, Lazarus HM, Reed MD, Sinclair JW, Haverstock DC, Kowalsky SF, Hurd DD, Cushing DA, Harman CP, Donowitz GR.
    Ann Intern Med; 2002 Jul 16; 137(2):77-87. PubMed ID: 12118962
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
    Fanci R, Paci C, Martinez RL, Fabbri A, Pecile P, Leoni F, Longo G.
    J Chemother; 2000 Jun 16; 12(3):232-9. PubMed ID: 10877519
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia.
    Meunier F, Van der Auwera P, Aoun M, Bron D.
    Br J Haematol; 1990 Dec 16; 76 Suppl 2():49-53. PubMed ID: 2149053
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.